Home Cart Sign in  
Chemical Structure| 72040-63-2 Chemical Structure| 72040-63-2

Structure of Biotin-C5-NHS Ester
CAS No.: 72040-63-2

Chemical Structure| 72040-63-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Synonyms: Biotin-X-NHS

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 72040-63-2 ]

CAS No. :72040-63-2
Formula : C20H30N4O6S
M.W : 454.54
SMILES Code : O=C(ON1C(CCC1=O)=O)CCCCCNC(CCCC[C@@H]2SC[C@]([C@]2([H])N3)([H])NC3=O)=O
Synonyms :
Biotin-X-NHS
MDL No. :MFCD00065502
InChI Key :UVGHPGOONBRLCX-NJSLBKSFSA-N
Pubchem ID :83874

Safety of [ 72040-63-2 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Application In Synthesis of [ 72040-63-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 72040-63-2 ]

[ 72040-63-2 ] Synthesis Path-Downstream   1~19

  • 1
  • N-(4-azido-2-nitrobenzoyl)-1,7-diaminoheptane [ No CAS ]
  • [ 72040-63-2 ]
  • 4-Azido-2-nitro-N-(7-{6-[5-(2-oxo-hexahydro-thieno[3,4-d]imidazol-6-yl)-pentanoylamino]-hexanoylamino}-heptyl)-benzamide [ No CAS ]
  • 2
  • [ 72040-63-2 ]
  • 5-(3-aminopropen-1-yl)-5'-O-(β,γ-diphosphoryl-α-phosphonomethyl)-2'-deoxyuridine [ No CAS ]
  • 5-[3-(N-biotinyl-6-aminohexanoylamino)propen-1-yl]-5'-O-(β,γ-diphosphoryl-α-phosphonomethyl)-2'-deoxyuridine [ No CAS ]
  • 3
  • [ 34284-75-8 ]
  • [ 72040-63-2 ]
  • 4-(2-{6-[5-(2-oxo-hexahydro-thieno[3,4-<i>d</i>]imidazol-6-yl)-pentanoylamino]-hexanoylamino}-ethyl)-benzenesulfonyl fluoride [ No CAS ]
  • 4
  • [ 72040-63-2 ]
  • [ 9050-30-0 ]
  • biotinylated heparan sulfate [ No CAS ]
YieldReaction ConditionsOperation in experiment
With sodium hydrogencarbonate; In water; dimethyl sulfoxide; at 20.0℃; for 1h;pH 8.5; Heparan sulfate (HS) was biotinylated using biotin with extended spacer arms usingsuccinimidyl-6- (biotinamido) hexanoate(NHS-LC-Biotin) obtained from Pierce. About 0.5 ml HS solution (2 mg/ml in NaHC03, pH 8.5) was mixed with 0.05 ml of a freshly prepared solution of NHS-LC-Biotin in dimethyl sulfoxide. The mixture was incubated at room temperature for 1 hour. Unconjugated biotin was removed by centrifugation (10,000 RPM) through Microcon-3 filter (Millipore) followed by dilution with phosphate buffered saline (PBS). This procedure was repeated five times to ensure complete removal of free biotin. Unwanted aldehydes in the reaction were then quenched by incubation with one milliliter of Tris-glycine <Desc/Clms Page number 357>buffer (25mM-183 mM, pH 8. 3) at room temperature for 20 minutes. The mixture was subjected to three rounds of microfiltration as described above. Biotinylated HS (5 mg/ml in PBS) was aliquoted and storedat-20 C. To obtain maximum biotinylation, a25-fold molar excess of biotin was used. Using HABA reagent, it was determined that the ratio of HS to biotin was 1: 2. The extent of biotinylation of HS was determined using Avidin-HABA (Pierce Chemical Co). The HABA assay can be used over a wide range of pH and salt concentrations. HABA (4-hydroxyazobenzene-2'-carboxylic acid) is a dye that binds to avidin and can serve as an indicator of unoccupied binding sites. Avidin combines stoichiometrically with biotin, making it possible to use any physiochemical differences between avidin and the avidin-biotin complex as the basis of a qualitative and quantitative assay method for either component. When HABA binds to avidin, there is a large spectral change in the HABA dye. A new absorption band appears at 500 nm, which is characteristic of the quinoid form of the dye. The avidin-biotin complex does not bind HABA and because the dissociation constant of the complex is so low, the dye is stoichiometrically displaced by biotin. Consequently, the HABA assay can be the basis of both colorimetric and titrimetric assays. The amount of avidin can be calculated directly from the increased absorbance at 500 nm, or the dye may be used as an indicator in a spectrophotometric titration with biotin. The absorption band that results from the avidin-HABA complex decreases proportionately when biotin is added. Since biotin has such a high affinity for avidin, it displaces the HABA dye. The unknown amount of biotin can be determined by preparing a standard curve using known amounts of biotin to displace the HABA which bound to avidin, and plotting against the absorbance at 500 mu. HABA solution was prepared by adding 24.2 mg of HABA (Pierce) to 9.9 ml H20, and then adding0. 1 ml1 M NaOH. Avidin-HABA reagent was prepared by adding 10 mg of avidin and 600 gl of HABA solution to 19.4 ml of phosphate buffered saline. To1 ml of Avidin-HABA reagent in a cuvette,100ul of biotinylated HS was added, and the optical density was measured at 500 nm in a spectrophotometer. A standard curve was determined using known amounts of HABA. The decrease in optical density of the HABA following the addition of biotinylated HS was determined.
  • 5
  • [ 6066-82-6 ]
  • [ 72040-64-3 ]
  • [ 72040-63-2 ]
  • 6
  • [ 51857-17-1 ]
  • [ 72040-63-2 ]
  • (6-{6-[5-(2-oxo-hexahydro-thieno[3,4-d]imidazol-4-yl)-pentanoylamino]-hexanoylamino}-hexyl)-carbamic acid tert-butyl ester [ No CAS ]
  • 7
  • [ 4443-68-9 ]
  • [ 72040-63-2 ]
  • 8
  • [ 72040-63-2 ]
  • 6-[5-(2-oxo-hexahydro-thieno[3,4-d]imidazol-4-yl)-pentanoylamino]-hexanoic acid (6-amino-hexyl)-amide trifluoroacetate [ No CAS ]
  • 9
  • [ 72040-63-2 ]
  • [(6-{6-[5-(2-oxo-hexahydro-thieno[3,4-d]imidazol-4-yl)-pentanoylamino]-hexanoylamino}-hexylcarbamoyl)-methyl]-carbamic acid tert-butyl ester [ No CAS ]
  • 10
  • [ 72040-63-2 ]
  • 6-[5-(2-oxo-hexahydro-thieno[3,4-d]imidazol-4-yl)-pentanoylamino]-hexanoic acid [6-(2-amino-acetylamino)-hexyl]-amide [ No CAS ]
  • 11
  • [ 72040-63-2 ]
  • 6-[5-(2-oxo-hexahydro-thieno[3,4-d]imidazol-4-yl)-pentanoylamino]-hexanoic acid [6-(2-amino-acetylamino)-hexyl]-amide trifluoroacetate [ No CAS ]
  • 12
  • [ 85718-04-3 ]
  • [ 72040-63-2 ]
  • 13
  • [ 60-32-2 ]
  • [ 72040-63-2 ]
YieldReaction ConditionsOperation in experiment
6-[5-(2-Oxo-hexahydro-thieno[3,4-d]imidazol-4-yl)-pentanoylamino]-hexanoic Acid 2,5-Dioxo-pyrrolidin-1-yl Ester (4)Synthesis of 4 with high purity was achieved following the method of Wilchek and Bayer with critical changes in workup procedures. 6-[5-(2-Oxo-hexahydro-thieno[3,4-d]imidazol-4-yl)-pentanoylamino]-hexanoic acid (3; 0.31 g, 0.87 mmol) was completely dissolved in DMF (20 mL) with gentle warming.After cooling the 3 solution to room temperature without reprecipitation, DCC (0.34 g, 1.65 mmol) and pyridine (0.07 mL, 0.83 mmol) were added to the solution while stirring for 5 min, followed by the addition of NHS (0.16 g, 1.46 mmol) with continuous stirring for 18 h.The reaction product was filtered and concentrated under reduced pressure.The remaining solid was redissolved in 2-propanol (40 mL) with gentle heating, cooled down to room temperature, and reprecipitated at 4° C. overnight.The product was scraped out of the glassware, washed with cold 2-propanol, and air-dried to obtain 4 (0.22 g; 56.8percent) as a white solid. 1H NMR (400 MHz) (DMSO) delta: 7.77 (s, 1H, CONH), 6.45 (s, 1H, CONH), 6.38 (s, 1H, CONH), 4.31 (t, 1H, CHN), 4.15 (t, 1H, CHN), 3.11 (dd, 1H, CHS), 3.03 (t, 2H, CH2NH), 2.83 (s, 4H, CH2 of NHS), 2.79 (d, 1H, CHHS), 2.67 (t, 2H, CH2COOH), 2.60 (d, 1H, CHHS), 2.06 (t, 2H, CH2CO), 1.04-1.75 (m, 12H).13C NMR (100.67 MHz) (DMSO) delta: 171.90, 170.36, 169.03, 162.79, 61.13, 59.27, 55.53, 38.14, 35.32, 30.24, 28.74, 28.32, 28.14, 25.54, 25.41, 24.05. HRMS (ESI) calculated for C20H30N4O6S, [M+Na]+ 477.1784 (calcd.), 477.1784 (found).
  • 15
  • C15H22N4O14P3(3-)*3Li(1+) [ No CAS ]
  • [ 72040-63-2 ]
  • C31H50N7O17P3S [ No CAS ]
  • 16
  • C17H21F3N4O15P3(3-)*3Li(1+) [ No CAS ]
  • [ 72040-63-2 ]
  • C31H50N7O17P3S [ No CAS ]
  • 17
  • 8-(6-iodo-benzo[1,3]dioxol-5-ylsulfanyl)-9-(3-isopropylamino-propyl)adenine [ No CAS ]
  • [ 72040-63-2 ]
  • [ 1418215-42-5 ]
YieldReaction ConditionsOperation in experiment
41% With N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 35.0℃; for 6h; 2 (15 mg, 0.0292 mmol), EZ-Link"' NHS-LC-Biotin (14.6 mg, 0.0321mmol) and DIEA (7.5 mg, 10.2f.IL, 0.0584 mmol) in DMF (0.5 mL) was heated at 35 °C for 6 h. Thereaction mixture was concentrated under reduced pressure and the resulting residue was purified bypreparatoryTLC (CH2Cl2:MeOH-NH, (7N), 10:1) to give 10.3 mg (41percent) ofPU-H71-biotin7.lnaddition, 6.9 mg ofunreacted 2 was recovered to give an actual yield of77percent. 1H NMR (500 MHz,CDCh, 2 rotamers) o 8.26-8.29 (m, H), 7.29 (s, 0.4H), 7.28 (s, 0.6H), 6.87 (s, 0.4H), 6.85 (s, 0.6H),6.76 (br s, 0.4H), 6.74 (br s, 0.6H), 6.51-6.63 (br s, 2H), 5.96-6.00 (m, 2H), 5.68 (hr s, 0.4H), 5.58 (br s, 0.6H), 4.56-4.64 (m, 0.4H), 4.45-4.52 (m, H), 4.28-4.36 (m, H), 4.20-4.27 (m, 2H), 4.01-4.09 (m,0.6H), 3.08-3.32 (m, 5H), 2.86-2.94 (m, IH), 2.69-2.76 (m, H), 2.31-2.37 (m, H), 1.96-2.22 (m,4H), 1.89-1.96 (m, H), 1.30-1.80 (m, 2H), 1.10-1.16 (m, 4H), 1.04-1.09 (m, 2H); MS (ESI): mlz852.3 [M+H]'.
  • 18
  • [ 1333155-97-7 ]
  • [ 72040-63-2 ]
  • [ 1418215-40-3 ]
YieldReaction ConditionsOperation in experiment
72% With N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20.0℃; for 1h; 13 (16.9 mg, 0.0359 mmol), EZ-Link" NHS-LC-Biotin (17 .9 mg, 0.0394mmol) and DIEA (9.3 mg, l2.5f.IL, 0.0718 mmol) in DMF (0.5 mL) was stirred at rt for l h. Thereaction mixture was concentrated under reduced pressure and the resulting residue was purified bypreparatory TLC (CH2Cl2:MeOH-NH3 (7N), 10: I) to give 20.8 mg (72percent) ofPU-H71-biotin4. 1HNMR (500 MHz, CDC,) o 8.22 (s, H), 7.52 (t, J = 5.6 Hz, IH), 7.36 (s, H), 7.03 (s, H), 6.66 (t, J= 5.5 Hz, H), 6.25 (br s, 2H), 6.03 (s, 2H), 4.47-4.52 (m, H), 4.28-4.33 (m, H), 4.25 (t, J = 6.8 Hz,2H), 3.17-3.25 (m, 4H), 3.11-3.17 (m, IH), 2.90 (dd, J= 5.0, 12.9 Hz, H), 2.63-2.79 (m, H), 2.24 (t,J= 7.4 Hz, 2H), 2.13-2.19 (m, 2H), 1.94-2.02 (m, 2H), 1.58-1.74 (m, 6H), 1.48-1.56 (m, 2H), 1.31-1.46 (m, 4H); MS (ESI): mlz 810.3 [M+Ht.
  • 19
  • C126H202N20O29S [ No CAS ]
  • C110H177N18O25Pol [ No CAS ]
  • [ 72040-63-2 ]
  • C95H146N20O22S [ No CAS ]
YieldReaction ConditionsOperation in experiment
Synthesis of Biotin-T-Epitope Peptide 27:Next, a mixture of EZ-Link® NHS-Biotin reagent (<strong>[72040-63-2]succinimidyl-6-(biotinamido)hexanoate</strong>) (0.2 mmol, 90 mg) and DIPEA (0.2 mmol, 36 muL) in DMF (5 mL) was added to the resin. The coupling was monitored by standard Kaiser test and was complete within 8 h. The resin was washed thoroughly with DMF (5 mL×2), DCM (5 mL×2), and MeOH (5 mL×2) and then dried in vacuo. The resin was swelled in DCM (5 mL) for 1 h and treated with reagent B (TFA (88percent), water (5percent), phenol (5percent), and TIS (2percent), 15 mL) for 2 h at room temperature. The resin was filtered and washed with neat TFA (2 mL). The filtrate was concentrated in vacuo to approximately of its original volume. The peptide was precipitated using diethyl ether (0° C.; 30 mL) and recovered by centrifugation at 3,000 rpm for 15 min. The crude peptide was purified by RP-HPLC on a semi preparative C-8 column using a linear gradient of 0 to 95percent solvent B in solvent A over a 40 min period and the appropriate fractions were lyophilized to afford 27 (FIG. 14) (60percent based on resin loading capacity). C95H147N21O21S, MALDI-ToF MS: observed [M+], 1951.2966 Da; calculated [M+], 1951.3768 Da.
 

Historical Records

Categories